Traditional vaccine
AN Oxford biotech company has won an international award for its 'innovative' needle-free vaccine.
Enesi Pharma has been developing a method of delivering a solid dose of a vaccine for a range of infectious diseases, which uses a device to implant it 2mm below the skin.
ALSO READ: Oxford risking covid lockdown as city nears 'red alert'
It has the advantage of being easier to transport, requiring little training, and reducing the risk of cross-infection, all while having the same potency as a traditional liquid vaccine.
It won Best New Vaccine Technology/Platform at the World Vaccine Congress.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here